Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +49.56%
#3 DOVU DOVU +49.39%
#4 Velvet Velvet +44.04%
#5 Black Phoenix Black Phoenix +34.54%
#6 Ο„emplar Ο„emplar +23.14%
#7 Cross Cross +18.32%
#8 Ribbita by Virtuals Ribbita by Virtuals +17.09%
#9 Cap Cap +16.96%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.04%
Coin of the day
Glidr Glidr
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Chimeric Therapeutics Limited Chimeric Therapeutics Limited

Chimeric Therapeutics Limited

CHM
Peringkat dalam Saham #38385
Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical... Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical firm dedicated to developing and commercializing a diverse array of cell therapies designed to combat various cancers. Its lead natural killer (NK) cell platform, CHM 0201, is currently undergoing Phase I clinical evaluation for both solid tumors and hematological malignancies. Another key candidate, CHM 1101 (a CLTX CAR T therapy), is also in Phase I trials, specifically targeting recurrent or progressive glioblastoma in patients expressing MMP2+. Beyond these, the company's development pipeline encompasses CHM 0301 for blood cancers; CLTX CAR NK (CHM 1301) and CDH17 CAR NK (CHM 2301) for solid tumors. The CLTX CAR T platform (CHM 1101) is additionally being investigated for melanoma, colorectal, and prostate cancers, while CDH17 CAR T (CHM 2101) is being developed for neuroendocrine, colorectal, pancreatic, and gastric cancers. Chimeric Therapeutics, headquartered in Carlton, Australia, was founded in 2020.
Harga Saham
$0.02468497
Kapitalisasi Pasar
$1.01M
Perubahan (1 hari)
-12.50%
Perubahan (1 tahun)
-87.34%
Negara
AU
Perdagangan Chimeric Therapeutics Limited (CHM)

Kategori

Healthcare
Riwayat hasil dividen untuk Chimeric Therapeutics Limited (CHM)
Hasil dividen (TTM) dari Chimeric Therapeutics Limited (simbol saham: CHM) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Chimeric Therapeutics Limited (CHM) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE